Reports for NAPROXEN
Ingredient
NAPROXEN
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 375MG 20MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2020-10-15 | 2021-03-17 | 126398 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 375MG 20MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2021-03-17 | 2021-04-19 | 135792 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 375MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2022-07-20 | 2022-09-07 | 165092 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 375MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2023-01-10 | 2023-02-14 | 180349 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 375MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2023-05-31 | 2023-08-29 | 193442 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 375MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2023-12-19 | 2024-01-16 | 213764 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 375MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2024-11-06 | 2025-03-26 | 242126 |
| NAPROSYN | 750MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-01-18 | 2023-05-26 | 181466 |
| NAPROSYN | 750MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-10-02 | 2024-10-03 | 239149 |
| NAPROSYN | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2018-06-13 | 2018-09-21 | 52317 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-NAPROXEN | 500MG | SUPPOSITORY | Discontinued | 2020-06-15 | 2021-10-27 | 117745 |
| PMS-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2020-06-15 | 2021-10-27 | 117865 |
| PRO-NAPROXEN EC - 375 | 375MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-05-14 | 2019-11-05 | 84067 |
| TEVA-NAPROXEN | 250MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14055 |